Mini-mental state examination in non-hospitalized post covid patients to identify cognitive decline

Abstract

The WHO referred to the SARS-CoV-2 illness as COVID-19, an acronym for ""coronavirus disease 2019."" After an infection has cleared up, some individuals have experienced temporary or even long-lasting cognitive problems. Patients with SARS-CoV-2 infections are included in this. Many of these individuals, including those with mild disease, have reported deficits in attention, executive functioning, language, processing speed, and memory, which are collectively referred to as ""brain fog"" symptoms. This cognitive impairment syndrome significantly increases the morbidity of post-Covid-19 diseases along with the prevalence of anxiety, sadness, sleep disorders, and fatigue. Therefore, we performed the MMSE test to determine whether or not non-hospitalized post-covid individuals experience cognitive decline. The study's eligibility parameters called for participants to be over 25 and non-hospitalized post-covid patients. Following this MMSE exam, it is evident that post-COVID individuals who were not hospitalized will not experience any cognitive decline in the future. Because Their average score, according to the results, was 29.1851. It is really almost on the spot. We may not have detected any cognitive deterioration in the patient because we only tested a small number of people.